Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Department of Pediatrics, |
RCV001523831 | SCV001478138 | pathogenic | Neurofibromatosis, type 1 | 2020-12-15 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV001523831 | SCV004374997 | pathogenic | Neurofibromatosis, type 1 | 2023-10-25 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Pro1442Leufs*6) in the NF1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NF1 are known to be pathogenic (PMID: 10712197, 23913538). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with pediatric cancer (PMID: 34308366). ClinVar contains an entry for this variant (Variation ID: 995900). For these reasons, this variant has been classified as Pathogenic. |